Napredna pretraga

Pregled bibliografske jedinice broj: 170864

The glutathione S-transferase polymorphisms in a control population and in Alzheimer's disease patients


Žuntar, Irena; Kalanj-Bognar, Svjetlana; Topić, Elizabeta; Petlevski, Roberta; Štefanović, Mario; Demarin, Vida
The glutathione S-transferase polymorphisms in a control population and in Alzheimer's disease patients // Clinical chemistry and laboratory medicine, 42 (2004), 3; 334-339 (međunarodna recenzija, članak, znanstveni)


Naslov
The glutathione S-transferase polymorphisms in a control population and in Alzheimer's disease patients

Autori
Žuntar, Irena ; Kalanj-Bognar, Svjetlana ; Topić, Elizabeta ; Petlevski, Roberta ; Štefanović, Mario ; Demarin, Vida

Izvornik
Clinical chemistry and laboratory medicine (1434-6621) 42 (2004), 3; 334-339

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Alzheimer's disease; Glutathione S-transferase P1; PCR-RFLP; Polymorphism.
(Alzheimer's disease; glutathione S-transferase P1; PCR-RFLP; polymorphism.)

Sažetak
In this study, we investigated the role of glutathione S-transferase P1 (GSTP1) polymorphisms in the pathogenesis of Alzheimer's disease (AD). We genotyped the GSTP1 polymorphisms in exon 5 (A313G) and exon 6 (C341T) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 56 Croatian patients with AD and 231 controls. Distributions and frequencies of GSTP1 genetic variants were not statistically different between AD patients and healthy controls. Higher frequencies of the mutant genotypes were observed in AD patients (13% for both A313G and C341T) when compared with control subjects (7% for A313G and 8% for C341T1, but association of GSTP1 GG (OR 2.057, 95% CI 0.796-5.315, p=0.094) and TT (OR 1.691, 95% CI 0.669-4.270, p=0.514) genotypes with an increased risk of AD was not confirmed by statistical analysis. The frequencies of GSTP1 alleles (A, B, C, D) did not significantly differ between AD patients and controls and they were indicated as follows: 52.7%, 15.2%, 12.5% and 19.6% for AD cases and 58.4%, 14.1%, 14.1% and 13.4% for controls. The estimation of the GSTP1 haplotype distribution showed that GSTP1*A/GSTP1*B and GSTP1*A/GSTP1*C haplotypes were less frequent, while GSTP1*B/GSTP1*B and GSTP1*C/GSTP1*D haplotypes were more frequent in AD patients than in controls. In conclusion, the involvement of GSTP1.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE